use of tobacco quickly produces a dependency as much physical
as psychological. The fundamental cause of this dependence is
nicotine, which has a high addictive capacity.
increases the risk of lung cancer in men 25 fold and in woman
12,5 fold. For heavy smokers (more than 25 cigarettes per day)
the risk of developing diseases is 40 times higher than in non
smokers. Addiction to tobacco increases the risk of cancer of
mouth, lip and pharynx eightfold and to a lesser proportion
cancer of the estomach, oesophagus and bladder.
recommended by this Pharmacy are aids to stop smoking provided
that the patient is pre-disposed to give up smoking.
(Pfizer) is specifically designed to partially activate the nicotinic
receptor and reduce the severity of the smoker's craving and the
withdrawal symptoms from nicotine. Moreover, if a person smokes
a cigarette while receiving treatment, Chantix has the potential
to diminish the sense of satisfaction associated with smoking.
This may help to prevent the cycle of nicotine addiction.
50 mg. 60 tablets
the desire to smoke. The treatment is of a 7-12 weeks duration.
patches provide the quantity of nicotine necessary to reduce
the symptoms of craving whilst giving up smoking. It gradually
reduces nicotine levels over a period of three months until
such time as the body is able to do without.
- General conditions:
the information provided from Roser Miro Pharmacy's Web is directed
to complement, not to substitute the existent relationship between
a patient and his or her doctor.
- Privacy and confidentiality
policy: Whatever communication conveyed through the Web of Roser Miró
Pharmacy is strictly confidential; although the electronic addresses
and their content can be kept, your information will not be shared
with any external source.
This Web is managed by Roser Miró pharmacy, legally established
in Escaldes, Principality of Andorra. The terms and conditions of
usage of this Web are protected under the laws that rule in Andorra.
Equally all its products and medicines have been authorized by the
Health and Social Health Ministry of the Government of Andorra.
- Links: The Web
of the pharmacy contains links to other Webs, normally those of the
labs which manufacture the different products. These links are offered
as services and information to provide the maximum information about
the products, medicines and treatments, relative to health and well-being.
- Financing and
advertising: This Web neither receives nor has any financing from
- The information
of this web has been produced by the pharmacists of Roser Miró
Pharmacy's team, starting from approvals and subsequent information
from the European medicines agency www.emea.europa.eu
and the USA Food and Drug administration www.fda.gov
and from the manufacturing pharmaceutical laboratories.
7th February 2009